The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
Open accessAbstract
Circular RNAs (circRNAs) represent a class of non-coding RNAs that play a vital role in modulating gene expression and several pathological responses.However, the expression profile and function of circRNAs in triple-negative breast cancer (TNBC) remain unknown.In the current study, we investigated the expression profile of human circRNAs in TNBC tissues and identified circEPSTI1 (hsa_ circRNA_000479) as a significantly upregulated circRNA.Methods: We performed circular RNA microarray assays to screen circular RNA expression profiles of TNBC and further investigated circEPSTI1.We observed the effect of circEPSTI1 on proliferation, clonal formation and apoptosis in TNBC by knocking downcircEPSTI1 in three TNBC cell lines.Based on the MRE analysis and luciferase reporter assay, we found that circEPSTI1 binds to miRNAs as a miRNA sponge and the co-target genes of miRNAs.We performed xenograft experiments in mice to confirm our findings.We evaluated circEPSTI1 levels in 240 TNBC patients by ISH.Results: Knockdown of circEPSTI1 inhibits TNBC cell proliferation and induces apoptosis.In vitro and in vivo experiments indicated that circEPSTI1 binds to miR-4753 and miR-6809 as a miRNA sponge to regulate BCL11A expression and affect TNBC proliferation and apoptosis.High levels of circEPSTI1 correlate with reduced survival in TNBC patients.Conclusions: The circEPSTI1-miR-4753/6809-BCL11A axis affect the proliferation and apoptosis of triple-negative breast cancer through the mechanism of competing endogenous RNAs (ceRNA).In addition, our results identify circEPSTI1 as an independent prognostic marker for survival in patients with TNBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Natural RNA circles function as efficient microRNA sponges
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., & Kjems, J. (2013) · Nature · doi:10.1038/nature11993 · Cited by 7,985
Predicting effective microRNA target sites in mammalian mRNAs
Agarwal, V., Bell, G. W., Nam, J.-W., & Bartel, D. P. (2015) · eLife · doi:10.7554/elife.05005 · Cited by 7,318
Finishing the euchromatic sequence of the human genome
International Human Genome Sequencing Consortium (2004) · Nature · doi:10.1038/nature03001 · Cited by 4,971
Circular RNAs are abundant, conserved, and associated with ALU repeats
Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., Marzluff, W. F., & Sharpless, N. E. (2013) · RNA · doi:10.1261/rna.035667.112 · Cited by 4,388
Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis
Li, Y., Zheng, Q., Bao, C., Li, S., Guo, W., Zhao, J., Chen, D., Gu, J., He, X., & Huang, S. (2015) · Cell Research · doi:10.1038/cr.2015.82 · Cited by 2,204
Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis
Legnini, I., Di Timoteo, G., Rossi, F., Morlando, M., Briganti, F., Sthandier, O., Fatica, A., Santini, T., Andronache, A., Wade, M., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.017 · Cited by 2,173
miRDB: an online resource for microRNA target prediction and functional annotations
Wong, N., & Wang, X. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1104 · Cited by 1,787
Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
Beermann, J., Piccoli, M.-T., Viereck, J., & Thum, T. (2016) · Physiological Reviews · doi:10.1152/physrev.00041.2015 · Cited by 1,726
Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2
Du, W. W., Yang, W., Liu, E., Yang, Z., Dhaliwal, P., & Yang, B. B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw027 · Cited by 1,699
Circular RNAs: diversity of form and function
Lasda, E., & Parker, R. (2014) · RNA · doi:10.1261/rna.047126.114 · Cited by 1,204
Triple-negative breast cancer: disease entity or title of convenience?
Carey, L., Winer, E., Viale, G., Cameron, D., & Gianni, L. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.154 · Cited by 783
Chen, J., Li, Y., Zheng, Q., Bao, C., He, J., Chen, B., Lyu, D., Zheng, B., Xu, Y., Long, Z., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.12.006 · Cited by 686
Self-citationCircular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway
Li, F., Zhang, L., Li, W., Deng, J., Zheng, J., An, M., Lu, J., & Zhou, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3469 · Cited by 637
DNA sequence and analysis of human chromosome 9
Humphray, S. J., Oliver, K., Hunt, A. R., Plumb, R. W., Loveland, J. E., Howe, K. L., Andrews, T. D., Searle, S., Hunt, S. E., Scott, C. E., et al. (2004) · Nature · doi:10.1038/nature02465 · Cited by 637
Weng, W., Wei, Q., Toden, S., Yoshida, K., Nagasaka, T., Fujiwara, T., Cai, S., Qin, H., Ma, Y., & Goel, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2541 · Cited by 510
Circular RNAs Are a Large Class of Animal RNAs with Regulatory Potency
Jens, M. (2014) · Springer Theses · doi:10.1007/978-3-319-07082-7_5 · Cited by 443
Bandi, N., Zbinden, S., Gugger, M., Arnold, M., Kocher, V., Hasan, L., Kappeler, A., Brunner, T., & Vassella, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4277 · Cited by 386
circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
He, R., Liu, P., Xie, X., Zhou, Y., Liao, Q., Xiong, W., Li, X., Li, G., Zeng, Z., & Tang, H. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0614-1 · Cited by 347
Self-citationNeben, K., Jauch, A., Hielscher, T., Hillengass, J., Lehners, N., Seckinger, A., Granzow, M., Raab, M. S., Ho, A. D., Goldschmidt, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.4923 · Cited by 233
Bandyopadhyay, S., & Mitra, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp503 · Cited by 226
Jiang, Y.-Z., Liu, Y.-R., Xu, X.-E., Jin, X., Hu, X., Yu, K.-D., & Shao, Z.-M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3284 · Cited by 192
Treatment of triple negative breast cancer (TNBC): current options and future perspectives
De Laurentiis, M., Cianniello, D., Caputo, R., Stanzione, B., Arpino, G., Cinieri, S., Lorusso, V., & De Placido, S. (2010) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(10)70025-6 · Cited by 184
Circular RNAs and their associations with breast cancer subtypes
Nair, A. A., Niu, N., Tang, X., Thompson, K. J., Wang, L., Kocher, J.-P., Subramanian, S., & Kalari, K. R. (2016) · Oncotarget · doi:10.18632/oncotarget.13134 · Cited by 161
miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression
Tang, H., Deng, M., Tang, Y., Xie, X., Guo, J., Kong, Y., Ye, F., Su, Q., & Xie, X. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1326 · Cited by 160
Self-citationBCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells
Khaled, W. T., Lee, S. C., Stingl, J., Chen, X., Ali, H. R., Rueda, O. M., Hadi, F., Wang, J., Yu, Y., Chin, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms6987 · Cited by 158
Self-citationGenome-wide Association Study Identifies Candidate Genes for Male Fertility Traits in Humans
Kosova, G., Scott, N. M., NIEDERBERGER, C. S., Prins, G. S., & Ober, C. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.04.016 · Cited by 149
miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer
Chen, B., Tang, H., Liu, X., Liu, P., Yang, L., Xie, X., Ye, F., Song, C., Xie, X., & Wei, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.028 · Cited by 98
Self-citationThe DNA sequence and analysis of human chromosome 13
Dunham, A., Matthews, L. H., Burton, J., Ashurst, J. L., Howe, K., Ashcroft, K. J., Beare, D. M., Burford, D. C., Hunt, S. E., Griffiths‐Jones, S., et al. (2004) · Nature · doi:10.1038/nature02379 · Cited by 97
Nielsen, H. L., Rønnov‐Jessen, L., Villadsen, R., & Petersen, O. W. (2002) · Genomics · doi:10.1006/geno.2002.6755 · Cited by 70
Koduru, S. V., Tiwari, A. K., Leberfinger, A. N., Hazard, S. W., Kawasawa, Y. I., Mahajan, M. C., & Ravnic, D. J. (2017) · Journal of Cancer · doi:10.7150/jca.17633 · Cited by 49
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study
Galasso, M., Costantino, G., Pasquali, L., Minotti, L., Baldassari, F., Corrà, F., Agnoletto, C., & Volinia, S. (2016) · International Journal of Genomics · doi:10.1155/2016/4503840 · Cited by 31
Hayakawa, K., Formica, A. M., Colombo, M., Shinton, S. A., Brill‐Dashoff, J., Morse, H. C., Li, Y., & Hardy, R. R. (2016) · Leukemia · doi:10.1038/leu.2016.61 · Cited by 24
Cited by
Circular RNA-protein interactions: functions, mechanisms, and identification
Huang, A., Zheng, H., Wu, Z., Chen, M., & Huang, Y. (2020) · Theranostics · doi:10.7150/thno.42174 · Cited by 907
The novel roles of circRNAs in human cancer
Shang, Q., Yang, Z., Jia, R., & Ge, S. (2019) · Molecular Cancer · doi:10.1186/s12943-018-0934-6 · Cited by 547
CircRNA in cancer: Fundamental mechanism and clinical potential
Chen, L., & Shan, G. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.004 · Cited by 535
Sang, Y., Chen, B., Song, X., Li, Y., Liang, Y., Han, D., Zhang, N., Zhang, H., Liu, Y., Chen, T., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.011 · Cited by 460
Self-citationCircRNAs: role in human diseases and potential use as biomarkers
Verduci, L., Tarcitano, E., Strano, S., Yarden, Y., & Blandino, G. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03743-3 · Cited by 374
Metadata
- Authors
- Chen, B., Wei, W., Huang, X., Xie, X., Kong, Y., Dai, D., Yang, L., Wang, J., Tang, H., & Xie, X.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2018
- Volume
- 8
- Issue
- 14
- Pages
- 4003-4015
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2849052994
- Cited by
- 281
- References
- 33
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.